223 related articles for article (PubMed ID: 17206639)
1. Azathioprine and mesalazine-induced effects on the mucosal flora in patients with IBD colitis.
Swidsinski A; Loening-Baucke V; Bengmark S; Lochs H; Dörffel Y
Inflamm Bowel Dis; 2007 Jan; 13(1):51-6. PubMed ID: 17206639
[TBL] [Abstract][Full Text] [Related]
2. Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease.
Swidsinski A; Weber J; Loening-Baucke V; Hale LP; Lochs H
J Clin Microbiol; 2005 Jul; 43(7):3380-9. PubMed ID: 16000463
[TBL] [Abstract][Full Text] [Related]
3. Spatial organization of bacterial flora in normal and inflamed intestine: a fluorescence in situ hybridization study in mice.
Swidsinski A; Loening-Baucke V; Lochs H; Hale LP
World J Gastroenterol; 2005 Feb; 11(8):1131-40. PubMed ID: 15754393
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of the intestinal mucus barrier in normal and inflamed colon.
Swidsinski A; Loening-Baucke V; Theissig F; Engelhardt H; Bengmark S; Koch S; Lochs H; Dörffel Y
Gut; 2007 Mar; 56(3):343-50. PubMed ID: 16908512
[TBL] [Abstract][Full Text] [Related]
5. Measurement of colonic mucosal concentrations of 5-aminosalicylic acid is useful for estimating its therapeutic efficacy in distal ulcerative colitis: comparison of orally administered mesalamine and sulfasalazine.
Naganuma M; Iwao Y; Ogata H; Inoue N; Funakoshi S; Yamamoto S; Nakamura Y; Ishii H; Hibi T
Inflamm Bowel Dis; 2001 Aug; 7(3):221-5. PubMed ID: 11515848
[TBL] [Abstract][Full Text] [Related]
6. Bacterial immune interaction in experimental colitis.
Xue LY; Ouyang Q; Zhou XG; Huang ZH; Chen W; Chen M; Yu LM
J Dig Dis; 2013 Oct; 14(10):526-35. PubMed ID: 23734583
[TBL] [Abstract][Full Text] [Related]
7. Mucosal 5-aminosalicylic acid concentration, drug formulation and mucosal microbiome in patients with quiescent ulcerative colitis.
Olaisen M; Spigset O; Flatberg A; Granlund AVB; Brede WR; Albrektsen G; Røyset ES; Gilde B; Sandvik AK; Martinsen TC; Fossmark R
Aliment Pharmacol Ther; 2019 May; 49(10):1301-1313. PubMed ID: 30895635
[TBL] [Abstract][Full Text] [Related]
8. 5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine.
Hande S; Wilson-Rich N; Bousvaros A; Zholudev A; Maurer R; Banks P; Makrauer F; Reddy S; Burakoff R; Friedman S
Inflamm Bowel Dis; 2006 Apr; 12(4):251-7. PubMed ID: 16633046
[TBL] [Abstract][Full Text] [Related]
9. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
10. The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics.
Linskens RK; Huijsdens XW; Savelkoul PH; Vandenbroucke-Grauls CM; Meuwissen SG
Scand J Gastroenterol Suppl; 2001; (234):29-40. PubMed ID: 11768558
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoid and dietary effects on mucosal microbiota in canine inflammatory bowel disease.
Atherly T; Rossi G; White R; Seo YJ; Wang C; Ackermann M; Breuer M; Allenspach K; Mochel JP; Jergens AE
PLoS One; 2019; 14(12):e0226780. PubMed ID: 31887117
[TBL] [Abstract][Full Text] [Related]
12. New strategies in the management of inflammatory bowel disease.
Rutgeerts P; Baert F
Acta Clin Belg; 1999 Oct; 54(5):274-80. PubMed ID: 10555385
[TBL] [Abstract][Full Text] [Related]
13. Mesalamine and azathioprine modulate junctional complexes and restore epithelial barrier function in intestinal inflammation.
Khare V; Krnjic A; Frick A; Gmainer C; Asboth M; Jimenez K; Lang M; Baumgartner M; Evstatiev R; Gasche C
Sci Rep; 2019 Feb; 9(1):2842. PubMed ID: 30809073
[TBL] [Abstract][Full Text] [Related]
14. Alterations in cytokine gene expression profile in colon mucosa of Inflammatory Bowel Disease patients on different therapeutic regimens.
Velikova T; Kyurkchiev D; Spassova Z; Karakolev I; Ivanova-Todorova E; Altankova I; Stanilova S
Cytokine; 2017 Apr; 92():12-19. PubMed ID: 28088612
[TBL] [Abstract][Full Text] [Related]
15. Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls.
Kleessen B; Kroesen AJ; Buhr HJ; Blaut M
Scand J Gastroenterol; 2002 Sep; 37(9):1034-41. PubMed ID: 12374228
[TBL] [Abstract][Full Text] [Related]
16. 5-ASA colonic mucosal concentrations resulting from different pharmaceutical formulations in ulcerative colitis.
D'Incà R; Paccagnella M; Cardin R; Pathak S; Baldo V; Giron MC; Sturniolo GC
World J Gastroenterol; 2013 Sep; 19(34):5665-70. PubMed ID: 24039359
[TBL] [Abstract][Full Text] [Related]
17. Thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease.
van Schaik FD; van Oijen MG; Smeets HM; van der Heijden GJ; Siersema PD; Oldenburg B
Gut; 2012 Feb; 61(2):235-40. PubMed ID: 21602529
[TBL] [Abstract][Full Text] [Related]
18. New genetic biomarkers predicting azathioprine blood concentrations in combination therapy with 5-aminosalicylic acid.
Uchiyama K; Takagi T; Iwamoto Y; Kondo N; Okayama T; Yoshida N; Kamada K; Katada K; Handa O; Ishikawa T; Yasuda H; Sakagami J; Konishi H; Yagi N; Naito Y; Itoh Y
PLoS One; 2014; 9(4):e95080. PubMed ID: 24762746
[TBL] [Abstract][Full Text] [Related]
19. Influence of Pharmaceutical Formulation on the Mucosal Concentration of 5-Aminosalicylic Acid and N-Acetylmesalamine in Japanese Patients with Ulcerative Colitis.
Yamamoto Y; Masuda S; Nakase H; Matsuura M; Maruyama S; Hisamatsu T; Suzuki Y; Matsubara K
Biol Pharm Bull; 2019 Jan; 42(1):81-86. PubMed ID: 30369547
[TBL] [Abstract][Full Text] [Related]
20. Mucosal barrier, bacteria and inflammatory bowel disease: possibilities for therapy.
Merga Y; Campbell BJ; Rhodes JM
Dig Dis; 2014; 32(4):475-83. PubMed ID: 24969297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
